Eric Weisblum
Chief Executive Officer, Director · Silo Pharma, Inc.
IndividualBuying only
- 2024
- Dec 16, 2025
- 5
Other insiders active in the same sector
No other insider has filed at Eric Weisblum's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric Weisblum?
Eric Weisblum is a corporate insider, tracked as Chief Executive Officer, Director of Silo Pharma, Inc. (SILO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eric Weisblum last file a Form 4?
The most recent primary Form 4 on record is dated 16 December 2025, one of 5 filings going back to 2024.
Has Eric Weisblum been buying or selling stock?
Recorded transactions: 9 open-market purchases ($14K) and 0 open-market sales across all tracked filings.
